明智的人
发表于 2025-3-26 23:04:06
Acivicin: A new antimetaboliteg toxicity of acivicin. This review will cover some of the experimental background of current clinical research involving acivicin, will relate clinical findings to the preclinical pharmacology of the drug, and will suggest some new directions for both clinical and preclinical research.
Parallel
发表于 2025-3-27 04:10:56
The clinical horizon of deoxycoformycinibitor of aspartate transcarbamylase. Pyrazofurin inhibits orotidylate synthetase irreversibly; both arrest de novo pyrimidine biosynthesis and are cytotoxic to several tumor models in vitro and in vivo. However, in extensive phase II clinical testing by the NCI in the past ten years, neither showed any reproducible activity.
不透明
发表于 2025-3-27 09:08:06
The View from Law and Economics of the theoretical and practical problems associated with the technique. Finally, a summary of recent single agent and combination intraperitoneal chemotherapy trials will be presented as well as a brief discussion of other innovative approaches utilizing the intraperitoneal route.
figurine
发表于 2025-3-27 12:10:52
http://reply.papertrans.cn/24/2350/234955/234955_34.png
GUILT
发表于 2025-3-27 17:16:06
http://reply.papertrans.cn/24/2350/234955/234955_35.png
Exonerate
发表于 2025-3-27 18:03:15
http://reply.papertrans.cn/24/2350/234955/234955_36.png
贞洁
发表于 2025-3-28 01:17:06
http://reply.papertrans.cn/24/2350/234955/234955_37.png
印第安人
发表于 2025-3-28 02:48:55
http://reply.papertrans.cn/24/2350/234955/234955_38.png
MIR
发表于 2025-3-28 07:52:54
http://reply.papertrans.cn/24/2350/234955/234955_39.png
ALOFT
发表于 2025-3-28 13:31:24
http://reply.papertrans.cn/24/2350/234955/234955_40.png